Abstract
SummaryThis discussion describes the long-term follow-up of a prospective randomized controlled trial evaluating the performance of the 2 most common biomesh products utilized in the context of complex abdominal wall reconstructions. Although the incidence of hernia recurrence increased over time to 26% (median follow-up 62 mo), both biomesh products performed similarly. Biomesh product choice should remain cost-conscious.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have